YUM
33
-2
AA
38
-2
CCL
51
3
JNJ
33
-12
ADT
43
2
AIZ
52
2
BWA
38
-6
XEL
51
8
ADP
66
4
LYB
34
-2
NAVI
35
-5
UHS
60
4
V
50
2
VIX
55
-5
CTSH
46
-3
SE
65
5
STI
10
-13
EXR
37
15
EIX
47
-11
OI
30
-4
YUM
33
-2
AA
38
-2
CCL
51
3
JNJ
33
-12
ADT
43
2
AIZ
52
2
BWA
38
-6
XEL
51
8
ADP
66
4
LYB
34
-2
NAVI
35
-5
UHS
60
4
V
50
2
VIX
55
-5
CTSH
46
-3
SE
65
5
STI
10
-13
EXR
37
15
EIX
47
-11
OI
30
-4
Financhill
Back

Sumitomo Realty & Development Vs. Novo Nordisk AS Industry Stock Comparison

Buy
56

SURDF
Sumitomo Realty & Development

Last Price:
$31.40
Seasonality Move:
-0.66%
Sell
25

NVO
Novo Nordisk AS

Last Price:
$86.31
Seasonality Move:
6.68%
Buy
56
Sumitomo Realty & Development (SURDF) is a Buy

Is Sumitomo Realty & Development a Buy, Sell or Hold?

  • The current Sumitomo Realty & Development [SURDF] share price is $31.40. The Score for SURDF is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • SURDF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.64. The Score for NVO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SURDF Stock Price Chart

What is Sumitomo Realty & Development's stock price today?

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

SURDF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.17 Buy
Relative Strength Index (14 RSI): 55.94 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.94 - 31.84) Buy
Bollinger Bands (100): (30.43 - 33.59) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.06 Sell
Relative Strength Index (14 RSI): 31.71 Sell
Chaikin Money Flow: 6521757 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.72 - 109.1) Sell
Bollinger Bands (100): (99.51 - 129.55) Sell

SURDF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.52 Sell
20-day SMA: 31.51 Sell
50-day SMA: 30.84 Buy
200-day SMA: 32.65 Sell
8-day EMA: 31.48 Sell
20-day EMA: 31.36 Buy
50-day EMA: 31.31 Buy
200-day EMA: 31.48 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 86.04 Sell
20-day SMA: 94.95 Sell
50-day SMA: 102.54 Sell
200-day SMA: 123.74 Sell
8-day EMA: 86.81 Sell
20-day EMA: 92.64 Sell
50-day EMA: 101.62 Sell
200-day EMA: 114.8 Sell

Sumitomo Realty & Development Earnings Growth & SURDF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.54 per share.

Sumitomo Realty & Development Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):